Drug Pipeline

Trilaciclib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07473128 Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage… Limited Stage Small Cell Lung Cancer Not Yet Recruiting
Phase 2
NCT05578326 Study of Trilaciclib and Lurbinectidin Lung Cancer Recruiting
NCT06370416 the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With… Non-small Cell Lung Cancer Enrolling by Invitation
NCT06027268 Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic… Metastatic Triple-Negative Breast Cancer Active, Not Recruiting
Sponsors Running Trilaciclib Trials
UNC Lineberger Comprehensive Cancer Center (1) Wake Forest University Health Sciences (1) Henan Cancer Hospital (1) Pharmacosmos A/S (1)
Disease Areas
Lung Cancer (3) Breast Cancer (1) Triple-Negative Breast Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1) Small Cell Lung Cancer (1)
Get alerts when Trilaciclib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free